BIO chief optimistic that most biotechs will survive recession

05/10/2009 | Boston Globe (tiered subscription model), The

Most biotech firms likely will survive the financial crisis despite a shortage in cash assets and the lack of investments brought about by the deep freeze in initial public offerings, BIO President and CEO James C. Greenwood said. In an interview with The Boston Globe, Greenwood also expressed support for the Obama administration's health care reform plan, saying a prioritization of innovation over cost reduction would benefit both the public and the industry.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN